MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3804-3812

  Trobonjaca, Z ^a   Leithauser F ^a   Moller P ^a   Bluethmann, H ^a   Koezuka, Y ^a   MacDonald, H R ^a   Reimann, J ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; HOMOZYGOTE; IMMUNE DEFICIENCY; KNOCKOUT GENE; LAMINA PROPRIA; LYMPHOCYTE TRANSFER; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TRANSGENIC MOUSE;

EID: 0035869589     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3804     Document Type: Article

References (59)

1. + T cells
2. hi T cells
3. + T cells are important for the balance between protective and pathogenic cell-mediated immunity
4. + T cells in the pathogenesis of murine inflammatory bowel disease
5. hi T cells to SCID recipients
6. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Star)-4 pathway, but is not conditional on interferon-γ expression by T cells
7. hi T cells
8. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
9. Mucosal immunity and inflammation: The yin and yang of T cells in intestinal inflammation: Pathogenic and protective roles in a mouse colitis model
10. The pathogenesis of mucosal inflammation in marine models of inflammatory bowel disease and Crohn disease
11. T cells in inflammatory bowel disease: Protective and pathogenic roles
12. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype
13. + T cells in an experimental model of colitis
14. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells
15. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
16. Targeted disruption of the MHC class II Aα gene in C57.BL/6 mice
17. + T cells in major histocompatibility complex class II-deficient mice
18. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response in vivo
19. Tissue-specific recognition of mouse CD1 molecules
20. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing
21. CD1.d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
22. CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease
23. + cells: New clues to their origin, specificity, and function
24. Mouse CD1-specific NKI T cells: Development, specificity, and function
25. CD1.d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
26. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells
27. CD1.d-mediated recognition of an a-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
28. + NK T lymphocytes
29. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
30. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (1L)-12 production by dendritic cells and 1L-12 receptor expression on NKT cells
31. Activation of NK T cells by CD1.d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
32. + T cell development and early IL-4 production in CD1-deficient mice
33. CD1.d1 mutant mice are deficient in natural T cells that promptly produce IL-4
34. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
35. Complexity of the mouse gut T cell immune system: Identification of two distinct natural killer T cell intraepithelial lineages
36. + cells in the liver of mice
37. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
38. Tracking the response of natural killer T cells to a glycolipid antigen using CD1,d tetramers
39. RAG-deficient mice have no mature B and T lymphocytes
40. + T cells
41. + αβ T cells in SCID mice with colitis
42. + TCR αβ T cells of athymic origin in histocompatible severe combined immunodeficient (SCID) mice
43. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony- stimulating factor
44. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type I response and ability to transfer disease
45. + T-cells in scid mice with inflammatory bowel disease
46. Murine CD1.d-restricted T cell recognition of cellular lipids
47. Molecular recognition of lipid antigens by T cell receptors
48. + T cells lose NK1.1 expression upon in vitro activation
49. + T cells
50. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo
51. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
52. lo T cells
53. + T cells
54. + T cells: A population of T cells with immune regulatory activities in vitro
55. + T cells are responsible for murine interleukin-2-deficient colitis
56. Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis
57. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes
58. + T cells reciprocally regulate acute graft versus host disease
59. A role for CD1 in the pathogenesis of lupus in NZB/NZW mice